nodes	percent_of_prediction	percent_of_DWPC	metapath
Micafungin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Micafungin—Jaundice—Mitoxantrone—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Micafungin—Urticaria—Teniposide—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Micafungin—Oliguria—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Micafungin—Abdominal pain—Teniposide—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Micafungin—Body temperature increased—Teniposide—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Micafungin—Erythema—Bleomycin—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Micafungin—Dyspnoea—Fludarabine—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Micafungin—Haematuria—Mitoxantrone—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Micafungin—Oedema peripheral—Carmustine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Micafungin—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Micafungin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Micafungin—Decreased appetite—Fludarabine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Micafungin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Micafungin—Fatigue—Fludarabine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Micafungin—Inflammation—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Micafungin—Constipation—Fludarabine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Micafungin—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Micafungin—Urinary tract disorder—Vincristine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Micafungin—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Micafungin—Urethral disorder—Vincristine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Micafungin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Micafungin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Micafungin—Flushing—Carmustine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Micafungin—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Micafungin—Anaemia—Bleomycin—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Micafungin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Micafungin—Asthenia—Teniposide—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Micafungin—Pruritus—Teniposide—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Micafungin—Arrhythmia—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Micafungin—Leukopenia—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Micafungin—Cardiac disorder—Vincristine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Micafungin—Skin exfoliation—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Micafungin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Micafungin—Mental disorder—Carmustine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Micafungin—Malnutrition—Carmustine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Micafungin—Erythema—Carmustine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Micafungin—Cough—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Micafungin—Angiopathy—Vincristine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Micafungin—Diarrhoea—Teniposide—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Micafungin—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Micafungin—Back pain—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Micafungin—Mental disorder—Vincristine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Micafungin—Chills—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Micafungin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Micafungin—Confusional state—Bleomycin—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Micafungin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Micafungin—Tremor—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Micafungin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Micafungin—Erythema—Mitoxantrone—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Micafungin—Infection—Bleomycin—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Micafungin—Anaemia—Carmustine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Micafungin—Back pain—Vincristine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Micafungin—Vomiting—Teniposide—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Micafungin—Sepsis—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Micafungin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Micafungin—Asthenia—Fludarabine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Micafungin—Rash—Teniposide—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Micafungin—Dermatitis—Teniposide—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Micafungin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Micafungin—Headache—Teniposide—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Micafungin—Pruritus—Fludarabine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Micafungin—Back pain—Mitoxantrone—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Micafungin—Leukopenia—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Micafungin—Anorexia—Bleomycin—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Micafungin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Micafungin—Anaemia—Vincristine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Micafungin—Hypotension—Bleomycin—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Micafungin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Micafungin—Convulsion—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Micafungin—Hypertension—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Micafungin—Nausea—Teniposide—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Micafungin—Anaemia—Mitoxantrone—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Micafungin—Hepatic failure—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Micafungin—Leukopenia—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Micafungin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Micafungin—Anxiety—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Micafungin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Micafungin—Renal failure acute—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Micafungin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Micafungin—Convulsion—Vincristine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Micafungin—Hypertension—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Micafungin—Confusional state—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Micafungin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Micafungin—Cough—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Micafungin—Infection—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Micafungin—Vomiting—Fludarabine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Micafungin—Convulsion—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Micafungin—Rash—Fludarabine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Micafungin—Dermatitis—Fludarabine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Micafungin—Hypertension—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Micafungin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Micafungin—Headache—Fludarabine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Micafungin—Tachycardia—Carmustine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Micafungin—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Micafungin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Micafungin—Anxiety—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Micafungin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Micafungin—Anorexia—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Micafungin—Infection—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Micafungin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Micafungin—Confusional state—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Micafungin—Nervous system disorder—Vincristine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Micafungin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Micafungin—Hypotension—Carmustine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Micafungin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Micafungin—Nausea—Fludarabine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Micafungin—Infection—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Micafungin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Micafungin—Shock—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Micafungin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Micafungin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Micafungin—Urticaria—Bleomycin—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Micafungin—Anorexia—Vincristine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Micafungin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Micafungin—Body temperature increased—Bleomycin—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Micafungin—Insomnia—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Micafungin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Micafungin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Micafungin—Hypotension—Vincristine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Micafungin—Dyspnoea—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Micafungin—Somnolence—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Micafungin—Anorexia—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Micafungin—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Micafungin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Micafungin—Decreased appetite—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Micafungin—Hypotension—Mitoxantrone—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Micafungin—Insomnia—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Micafungin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Micafungin—Constipation—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Micafungin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Micafungin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Micafungin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Micafungin—Decreased appetite—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Micafungin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Micafungin—Somnolence—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Micafungin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Micafungin—Feeling abnormal—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Micafungin—Fatigue—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Micafungin—Asthenia—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Micafungin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Micafungin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Micafungin—Constipation—Vincristine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Micafungin—Pruritus—Bleomycin—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Micafungin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Micafungin—Eosinophilia—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Micafungin—Fatigue—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Micafungin—Constipation—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Micafungin—Body temperature increased—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Micafungin—Abdominal pain—Carmustine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Micafungin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Micafungin—Pancytopenia—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Micafungin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Micafungin—Neutropenia—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Micafungin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Micafungin—Abdominal pain—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Micafungin—Body temperature increased—Vincristine—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Micafungin—Urticaria—Mitoxantrone—lymphatic system cancer	0.001	0.001	CcSEcCtD
Micafungin—Hypersensitivity—Carmustine—lymphatic system cancer	0.001	0.001	CcSEcCtD
Micafungin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000998	0.000998	CcSEcCtD
Micafungin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000998	0.000998	CcSEcCtD
Micafungin—Pneumonia—Methotrexate—lymphatic system cancer	0.000992	0.000992	CcSEcCtD
Micafungin—Vomiting—Bleomycin—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Micafungin—Infestation NOS—Methotrexate—lymphatic system cancer	0.000986	0.000986	CcSEcCtD
Micafungin—Infestation—Methotrexate—lymphatic system cancer	0.000986	0.000986	CcSEcCtD
Micafungin—Rash—Bleomycin—lymphatic system cancer	0.000981	0.000981	CcSEcCtD
Micafungin—Dermatitis—Bleomycin—lymphatic system cancer	0.00098	0.00098	CcSEcCtD
Micafungin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000977	0.000977	CcSEcCtD
Micafungin—Asthenia—Carmustine—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Micafungin—Renal failure—Methotrexate—lymphatic system cancer	0.000969	0.000969	CcSEcCtD
Micafungin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Micafungin—Haematuria—Methotrexate—lymphatic system cancer	0.00094	0.00094	CcSEcCtD
Micafungin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Micafungin—Epistaxis—Methotrexate—lymphatic system cancer	0.00093	0.00093	CcSEcCtD
Micafungin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00093	0.00093	CcSEcCtD
Micafungin—Asthenia—Vincristine—lymphatic system cancer	0.00093	0.00093	CcSEcCtD
Micafungin—Diarrhoea—Carmustine—lymphatic system cancer	0.000929	0.000929	CcSEcCtD
Micafungin—Nausea—Bleomycin—lymphatic system cancer	0.000924	0.000924	CcSEcCtD
Micafungin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000905	0.000905	CcSEcCtD
Micafungin—Dizziness—Carmustine—lymphatic system cancer	0.000898	0.000898	CcSEcCtD
Micafungin—Diarrhoea—Vincristine—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Micafungin—Hepatitis—Methotrexate—lymphatic system cancer	0.000885	0.000885	CcSEcCtD
Micafungin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000874	0.000874	CcSEcCtD
Micafungin—Urethral disorder—Methotrexate—lymphatic system cancer	0.000868	0.000868	CcSEcCtD
Micafungin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000864	0.000864	CcSEcCtD
Micafungin—Vomiting—Carmustine—lymphatic system cancer	0.000863	0.000863	CcSEcCtD
Micafungin—Dizziness—Vincristine—lymphatic system cancer	0.000857	0.000857	CcSEcCtD
Micafungin—Rash—Carmustine—lymphatic system cancer	0.000856	0.000856	CcSEcCtD
Micafungin—Dermatitis—Carmustine—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Micafungin—Headache—Carmustine—lymphatic system cancer	0.00085	0.00085	CcSEcCtD
Micafungin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000837	0.000837	CcSEcCtD
Micafungin—Vomiting—Vincristine—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Micafungin—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000821	0.000821	CcSEcCtD
Micafungin—Rash—Vincristine—lymphatic system cancer	0.000817	0.000817	CcSEcCtD
Micafungin—Dermatitis—Vincristine—lymphatic system cancer	0.000816	0.000816	CcSEcCtD
Micafungin—Headache—Vincristine—lymphatic system cancer	0.000812	0.000812	CcSEcCtD
Micafungin—Nausea—Carmustine—lymphatic system cancer	0.000806	0.000806	CcSEcCtD
Micafungin—Angiopathy—Methotrexate—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Micafungin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000802	0.000802	CcSEcCtD
Micafungin—Immune system disorder—Methotrexate—lymphatic system cancer	0.000799	0.000799	CcSEcCtD
Micafungin—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.000798	0.000798	CcSEcCtD
Micafungin—Rash—Mitoxantrone—lymphatic system cancer	0.000796	0.000796	CcSEcCtD
Micafungin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000795	0.000795	CcSEcCtD
Micafungin—Chills—Methotrexate—lymphatic system cancer	0.000794	0.000794	CcSEcCtD
Micafungin—Headache—Mitoxantrone—lymphatic system cancer	0.000791	0.000791	CcSEcCtD
Micafungin—Mental disorder—Methotrexate—lymphatic system cancer	0.000775	0.000775	CcSEcCtD
Micafungin—Erythema—Methotrexate—lymphatic system cancer	0.00077	0.00077	CcSEcCtD
Micafungin—Malnutrition—Methotrexate—lymphatic system cancer	0.00077	0.00077	CcSEcCtD
Micafungin—Nausea—Vincristine—lymphatic system cancer	0.00077	0.00077	CcSEcCtD
Micafungin—Dysgeusia—Methotrexate—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Micafungin—Nausea—Mitoxantrone—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Micafungin—Back pain—Methotrexate—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Micafungin—Anaemia—Methotrexate—lymphatic system cancer	0.000712	0.000712	CcSEcCtD
Micafungin—Leukopenia—Methotrexate—lymphatic system cancer	0.00069	0.00069	CcSEcCtD
Micafungin—Cough—Methotrexate—lymphatic system cancer	0.000672	0.000672	CcSEcCtD
Micafungin—Convulsion—Methotrexate—lymphatic system cancer	0.000668	0.000668	CcSEcCtD
Micafungin—Arthralgia—Methotrexate—lymphatic system cancer	0.000656	0.000656	CcSEcCtD
Micafungin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000651	0.000651	CcSEcCtD
Micafungin—Confusional state—Methotrexate—lymphatic system cancer	0.000634	0.000634	CcSEcCtD
Micafungin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000629	0.000629	CcSEcCtD
Micafungin—Infection—Methotrexate—lymphatic system cancer	0.000625	0.000625	CcSEcCtD
Micafungin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000617	0.000617	CcSEcCtD
Micafungin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000616	0.000616	CcSEcCtD
Micafungin—Skin disorder—Methotrexate—lymphatic system cancer	0.000611	0.000611	CcSEcCtD
Micafungin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000608	0.000608	CcSEcCtD
Micafungin—Anorexia—Methotrexate—lymphatic system cancer	0.000599	0.000599	CcSEcCtD
Micafungin—Hypotension—Methotrexate—lymphatic system cancer	0.000588	0.000588	CcSEcCtD
Micafungin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000573	0.000573	CcSEcCtD
Micafungin—Insomnia—Methotrexate—lymphatic system cancer	0.000569	0.000569	CcSEcCtD
Micafungin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000561	0.000561	CcSEcCtD
Micafungin—Somnolence—Methotrexate—lymphatic system cancer	0.000559	0.000559	CcSEcCtD
Micafungin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000553	0.000553	CcSEcCtD
Micafungin—Decreased appetite—Methotrexate—lymphatic system cancer	0.000547	0.000547	CcSEcCtD
Micafungin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000543	0.000543	CcSEcCtD
Micafungin—Fatigue—Methotrexate—lymphatic system cancer	0.000542	0.000542	CcSEcCtD
Micafungin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000518	0.000518	CcSEcCtD
Micafungin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000514	0.000514	CcSEcCtD
Micafungin—Urticaria—Methotrexate—lymphatic system cancer	0.0005	0.0005	CcSEcCtD
Micafungin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000497	0.000497	CcSEcCtD
Micafungin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000497	0.000497	CcSEcCtD
Micafungin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000463	0.000463	CcSEcCtD
Micafungin—Asthenia—Methotrexate—lymphatic system cancer	0.000451	0.000451	CcSEcCtD
Micafungin—Pruritus—Methotrexate—lymphatic system cancer	0.000445	0.000445	CcSEcCtD
Micafungin—Diarrhoea—Methotrexate—lymphatic system cancer	0.00043	0.00043	CcSEcCtD
Micafungin—Dizziness—Methotrexate—lymphatic system cancer	0.000416	0.000416	CcSEcCtD
Micafungin—Vomiting—Methotrexate—lymphatic system cancer	0.0004	0.0004	CcSEcCtD
Micafungin—Rash—Methotrexate—lymphatic system cancer	0.000396	0.000396	CcSEcCtD
Micafungin—Dermatitis—Methotrexate—lymphatic system cancer	0.000396	0.000396	CcSEcCtD
Micafungin—Headache—Methotrexate—lymphatic system cancer	0.000394	0.000394	CcSEcCtD
Micafungin—Nausea—Methotrexate—lymphatic system cancer	0.000373	0.000373	CcSEcCtD
